$IMLFF #OTCQX International InMed Pharmaceuticals, Inc. (IMLFF: OTCQX International) | InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
Copyright 2019 – OTC Markets Group Inc.

News Link